Quality of Life, Efficacy, and Safety of Sequential Intravesical Gemcitabine + Docetaxel versus BCG for Non-Muscle Invasive Urinary Bladder Cancer: A Pilot Study

Tarun Pareek(Post Graduate Institute of Medical Education and Research), Santosh Kumar(Post Graduate Institute of Medical Education and Research), Kalpesh Parmar(Post Graduate Institute of Medical Education and Research), Aditya Sharma(University of Manitoba)
Urologia Internationalis
January 1, 2022
Cited by 19


Related Papers